Shares of Transcat, Inc. (NASDAQ:TRNS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $130.25.
Several brokerages have recently issued reports on TRNS. Northland Securities decreased their target price on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. HC Wainwright restated a “buy” rating and set a $156.00 price objective on shares of Transcat in a report on Tuesday, October 29th. Oppenheimer reiterated an “outperform” rating and issued a $130.00 target price (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Craig Hallum raised their price target on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, StockNews.com downgraded Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th.
Read Our Latest Research Report on TRNS
Institutional Inflows and Outflows
Transcat Stock Performance
Transcat stock opened at $105.98 on Friday. Transcat has a fifty-two week low of $94.29 and a fifty-two week high of $147.12. The firm’s 50-day simple moving average is $105.91 and its 200 day simple moving average is $117.02. The stock has a market cap of $974.91 million, a PE ratio of 53.53 and a beta of 0.71.
Transcat (NASDAQ:TRNS – Get Free Report) last announced its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). The business had revenue of $67.83 million during the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. Transcat’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.41 EPS. As a group, analysts predict that Transcat will post 1.76 EPS for the current fiscal year.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Further Reading
- Five stocks we like better than Transcat
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Using the MarketBeat Dividend Yield Calculator
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to Use the MarketBeat Dividend Calculator
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.